American doctors have now discovered the injections put users at 'significantly higher' risk compared to three other common diabetes drugs.
The study in Nature Medicine reveals that alongside weight loss benefits, GLP-1 medications like Ozempic and Mounjaro may ...
American doctors have now discovered the injections put users at 'significantly higher' risk compared to three other common diabetes drugs.
Sino Biopharmaceutical CEO Eric Tse discusses the outlook of the company, Asian pharmaceutical markets, and the potential impacts from US President Donald Trump's tariffs and policy. Tse speaks to ...